| Nr. | Numele studiului | Status | Locatia/Locatiile studiului |
| 1 | A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (ARROW2) | In curs de recrutate | Research Site, Bucharest, Romania, 022328Research Site, Bucharest, Romania, 030171Research Site, Bucharest, Romania, 050098Research Site, Bucuresti, Romania, 020125Research Site, Cluj-Napoca, Romania, 400124Research Site, Iasi, Romania, 700483Research Site, Oradea, Romania, 410469Research Site, Sibiu, Romania, 550245Research Site, Timisoara, Romania, 300079 |
| 2 | Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. (CANDOR) | Activ, inca nu se recruteaza | Research Site, Brasov, Romania, 500152Research Site, Bucharest, Romania, 030171Research Site, Bucharest, Romania, 050098Research Site, Bucuresti, Romania, 020125Research Site, Bucuresti, Romania, 022328Research Site, Cluj-Napoca, Romania, 400124Research Site, Craiova, Romania, 200143 |
| 3 | Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma (ELOQUENT – 1) | Activ, inca nu se recruteaza | Local Institution, Brasov, Romania, 500152Local Institution, Bucuresti, Romania, 030171Local Institution, Bucuresti, Romania, 020125Local Institution, Bucuresti, Romania, 050098Local Institution, Bucuresti, Romania, 22328Local Institution, Iasi, Romania, 700483 |
| 4 | Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma (BOSTON) | Activ, inca nu se recruteaza | Hyperclnical MedLife PDR Vulturului Brasov, Hematology Department, Braşov, Romania, 500366Colentina Clinical Hospital, Department of Hematology, Bucharest, Romania, 020125Bucharest University Emergency Hospital, Department of Hematology, Bucharest, Romania, 050098 |
| 5 | A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma | Activ, inca nu se recruteaza | Brasov, RomaniaBucharest, RomaniaIasi, Romania |
| 6 | A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide (OCEAN) | Activ, inca nu recruteaza | RO-02, Braşov, RomaniaRO-01, Bucharest, Romania |
(Visited 67 times, 1 visits today)